Terms: = Head and neck cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Treatment
163 results:
1. The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal cancer Patients Who Receive Curative treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kato A; Kazama K; Tamagawa A; Cho H; Nakazono M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
Anticancer Res; 2024 May; 44(5):2185-2192. PubMed ID: 38677744
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study.
Li N; Li Z; Fu Q; Zhang B; Zhang J; Wan XB; Lu CM; Wang JB; Deng WY; Ma YJ; Bie LY; Wang MY; Li J; Xia QX; Wei C; Luo SX
Int J Surg; 2024 Apr; 110(4):2071-2084. PubMed ID: 38320099
[TBL] [Abstract] [Full Text] [Related]
3. Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal cancer Patients.
Mantziari S; Farinha HT; Messier M; Winiker M; Allemann P; Ozsahin EM; Demartines N; Piessen G; Schäfer M
Ann Surg Oncol; 2024 Apr; 31(4):2499-2508. PubMed ID: 38198002
[TBL] [Abstract] [Full Text] [Related]
4. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Shitara K; Rha SY; Wyrwicz LS; Oshima T; Karaseva N; Osipov M; Yasui H; Yabusaki H; Afanasyev S; Park YK; Al-Batran SE; Yoshikawa T; Yanez P; Dib Bartolomeo M; Lonardi S; Tabernero J; Van Cutsem E; Janjigian YY; Oh DY; Xu J; Fang X; Shih CS; Bhagia P; Bang YJ;
Lancet Oncol; 2024 Feb; 25(2):212-224. PubMed ID: 38134948
[TBL] [Abstract] [Full Text] [Related]
5. Deep learning-based outcome prediction using PET/CT and automatically predicted probability maps of primary tumor in patients with oropharyngeal cancer.
De Biase A; Ma B; Guo J; van Dijk LV; Langendijk JA; Both S; van Ooijen PMA; Sijtsema NM
Comput Methods Programs Biomed; 2024 Feb; 244():107939. PubMed ID: 38008678
[TBL] [Abstract] [Full Text] [Related]
6. Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and 399FF">neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE).
Yokota T; Zenda S; Kodaira T; Kiyota N; Fujimoto Y; Wasano K; Takahashi R; Mizowaki T; Homma A; Sasaki K; Machida R; Sekino Y; Fukuda H; ;
BMC Cancer; 2023 Nov; 23(1):1068. PubMed ID: 37932681
[TBL] [Abstract] [Full Text] [Related]
7. Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy.
Zheng M; Wang S; Zhu Y; Wan H
Support Care Cancer; 2023 Oct; 31(12):630. PubMed ID: 37843679
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning to predict curative multidisciplinary team treatment decisions in oesophageal cancer.
Thavanesan N; Bodala I; Walters Z; Ramchurn S; Underwood TJ; Vigneswaran G
Eur J Surg Oncol; 2023 Nov; 49(11):106986. PubMed ID: 37463827
[TBL] [Abstract] [Full Text] [Related]
9. Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells.
Zhang GQ; Xi C; Shen CT; Song HJ; Luo QY; Qiu ZL
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37260320
[TBL] [Abstract] [Full Text] [Related]
10. Health outcomes and budget impact projection of anti-PD-(L)1s in cancer care in Portugal.
Costa L; Alexandre T; Mansinho A; Sousa R; Vieira C; Hughes R; Roediger A; Pereira SM; Araújo A
Front Public Health; 2023; 11():1133959. PubMed ID: 37250095
[TBL] [Abstract] [Full Text] [Related]
11. Papillary thyroid carcinoma with desmoid-type fibromatosis: the clinicopathological features with characteristic imaging and molecular correlation requiring comprehensive treatment.
Huang H; Li L; Liu X; Zhao L; Cui Z; Zhang R; Chen S
Hum Pathol; 2023 Jun; 136():84-95. PubMed ID: 37019411
[TBL] [Abstract] [Full Text] [Related]
12. Single inferior parathyroid autotransplantation during total thyroidectomy with bilateral central lymph node dissection for papillary thyroid carcinoma: a retrospective cohort study.
Dong Z; Liu W; Peng Y; Zhan X; Su Y; Diao C; Cheng R
World J Surg Oncol; 2023 Mar; 21(1):102. PubMed ID: 36959661
[TBL] [Abstract] [Full Text] [Related]
13. Pre-immunotherapy radiotherapy enhanced the efficacy of multi-line sintilimab in unresectable advanced esophageal squamous cell carcinoma.
Xu S; Xu X; Zhu H
Front Immunol; 2023; 14():960339. PubMed ID: 36891294
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic prediction of lung adenocarcinoma by integrative analysis of rhoh expression and methylation.
Kuang M; Zhou Z; Lu Z; Shen W; Ge H; Tao X; Zhao Y; Zhuge L; Sun Y; Ji D; Zhang H
Clin Respir J; 2023 Mar; 17(3):148-156. PubMed ID: 36710485
[TBL] [Abstract] [Full Text] [Related]
15. Outcomes for recurrent oral cavity squamous cell carcinoma.
Contrera KJ; Zafereo ME; Yaniv D; Roberts DB; Gillenwater AM; Hanna EY; Weber RS; Myers JN; Chang EI; Garvey PB; Hanasono MM; Yu P; Hutcheson KA; Fuller CD; Tyler MA; Neskey DM
Oral Oncol; 2022 Nov; 134():106127. PubMed ID: 36155359
[TBL] [Abstract] [Full Text] [Related]
16. [Influencing factors of nutritional status and change in 50 patients with oral squamous cell carcinoma during treatment].
Maierhaba M; Bai J; Rusitanmu Y; Yao ZT
Shanghai Kou Qiang Yi Xue; 2022 Apr; 31(2):205-210. PubMed ID: 36110082
[TBL] [Abstract] [Full Text] [Related]
17. Propensity Score Matched Outcome Analysis of Lobar Ablation Versus Completion Thyroidectomy in Low-Risk Differentiated Thyroid cancer Patients: Median Follow-Up of 11 Years.
Bal C; Satapathy S; Tupalli A; Ballal S
Thyroid; 2022 Oct; 32(10):1220-1228. PubMed ID: 35983596
[No Abstract] [Full Text] [Related]
18. Multi-institutional Care in Clinical Stage II and III Esophageal cancer.
Rhodin KE; Raman V; Jensen CW; Kang L; Nussbaum DP; Tong BC; Blazer DG; D'Amico TA
Ann Thorac Surg; 2023 Feb; 115(2):370-377. PubMed ID: 35872035
[TBL] [Abstract] [Full Text] [Related]
19. Can Lymphovascular Invasion be Predicted by Preoperative Contrast-Enhanced CT in Esophageal Squamous Cell Carcinoma?
Chen W; Wang Y; Bai G; Hu C
Technol Cancer Res Treat; 2022; 21():15330338221111229. PubMed ID: 35790460
[No Abstract] [Full Text] [Related]
20. Nivolumab for recurrent or metastatic head and 399FF">neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study.
Ueda Y; Okano S; Enokida T; Fujisawa T; Ito K; Sato M; Tanaka H; Wada A; Tahara M
Oral Oncol; 2022 Jul; 130():105932. PubMed ID: 35636078
[TBL] [Abstract] [Full Text] [Related]
[Next]
